Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Litvan

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Dementia and Geriatric Cognitive Disorders Extra|September 11, 2012
Roles of Education and IQ in Cognitive Reserve in Parkinson's Disease-Mild Cognitive ImpairmentM J Armstrong, G Naglie, S Duff-Canning, et al.
Neurology|July 1, 1997
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic studyI Litvan, Y Agid, N Sastry, et al.
Journal of the Neurological Sciences|May 1, 1999
Consensus statement on the diagnosis of multiple system atrophyS Gilman, P A Low, N Quinn, et al.
Journal of the Autonomic Nervous System|January 23, 1999
Consensus statement on the diagnosis of multiple system atrophyS Gilman, P A Low, N Quinn, et al.
Neurology|June 27, 2001
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotypeH Houlden, M Baker, H R Morris, et al.
European Journal of Neurology|April 15, 2009
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment optionsA C Ludolph, J Kassubek, B G Landwehrmeyer, et al.
Neurology|December 14, 2005
BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD StudyS Karamohamed, J C Latourelle, B A Racette, et al.
Neurology|December 28, 2006
Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD StudyJ B Wilk, J E Tobin, O Suchowersky, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degenerationK B Casaletto, A M Staffaroni, A Wolf, et al.
Neurology|May 30, 2008
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD StudyJ E Tobin, J C Latourelle, M F Lew, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Dementia and Geriatric Cognitive Disorders Extra|September 11, 2012
Roles of Education and IQ in Cognitive Reserve in Parkinson's Disease-Mild Cognitive ImpairmentM J Armstrong, G Naglie, S Duff-Canning, et al.
Neurology|July 1, 1997
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic studyI Litvan, Y Agid, N Sastry, et al.
Journal of the Neurological Sciences|May 1, 1999
Consensus statement on the diagnosis of multiple system atrophyS Gilman, P A Low, N Quinn, et al.
Journal of the Autonomic Nervous System|January 23, 1999
Consensus statement on the diagnosis of multiple system atrophyS Gilman, P A Low, N Quinn, et al.
Neurology|June 27, 2001
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotypeH Houlden, M Baker, H R Morris, et al.
European Journal of Neurology|April 15, 2009
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment optionsA C Ludolph, J Kassubek, B G Landwehrmeyer, et al.
Neurology|December 14, 2005
BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD StudyS Karamohamed, J C Latourelle, B A Racette, et al.
Neurology|December 28, 2006
Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD StudyJ B Wilk, J E Tobin, O Suchowersky, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degenerationK B Casaletto, A M Staffaroni, A Wolf, et al.
Neurology|May 30, 2008
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD StudyJ E Tobin, J C Latourelle, M F Lew, et al.
Pageof 13